GWP GW Pharm.

RNS Number:3780G
GW Pharmaceuticals PLC
20 January 2003

                                  SCHEDULE 11

          NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS

1)       Name of company

         GW Pharmaceuticals plc

2)       Name of director

         David Mace

3)       Please state whether notification indicates that it is in respect of 
         holding of the shareholder named in 2 above or in respect of a 
         non-beneficial interest or in the case of an individual holder if it 
         is a holding of that person's spouse or children under the age of 18 
         or in respect of a non-beneficial interest

         As in 2 above

4)       Name of the registered holder(s) and, if more than one holder, the 
         number of shares held by each of them (if notified)


5)       Please state whether notification relates to a person(s) connected with 
         the Director named in 2 above and identify the connected person(s)


6)       Please state the nature of the transaction. For PEP transactions please 
         indicate whether general/single co PEP and if discretionary/non 
         discretionary


7)       Nmber of shares/amount of stock acquired

8)       Percentage of issued class

9)       Number of shares/amount of stock disposed

10)      Percentage of issued class

11)      Class of security

12)      Price per share

13)      Date of transaction

14)      Date company informed

15)      Total holding following this notification

16)      Total percentage holding of issued class following this notification

If a director has been granted options by the company please complete the 
following boxes

17)      Date of grant

          16th January 2003

18)      Period during which or date on which exercisable

          16th January 2006 - 16th January 2013

19)      Total amount paid (if any) for grant of the option

          N/A

20)      Description of shares or debentures involved: class, number

         37,500 Ordinary Shares of 0.1p each

21)      Exercise price (if fixed at time of grant) or indication that price is 
         to be fixed at time of exercise

          171p per share

22)      Total number of shares or debentures over which options held following 
         this notification

          182,500

23)      Any additional information


24)      Name of contact and telephone number for queries

         Jonathan Laughton, +44 (0)1980 557 000

25)      Name and signature of authorised company official responsible for 
         making this notification

          As above

Date of Notification

         20th January 2003


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

RDSEAAFEASADEFE

Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jun 2024 to Jul 2024

Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jul 2023 to Jul 2024